Health Canada Authorizes North America’s First Hepatitis B Rapid Test

Health Canada has authorized bioLytical Laboratories Inc.’s iStatis Hepatitis B Surface Antigen Test, marking it as the first rapid point-of-care test for hepatitis B in North America. This test provides results in 15 minutes and is aimed at improving access to hepatitis B screening and diagnosis, particularly in underserved communities. The test allows for quick detection of active infections, enabling timely medical responses.